<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00768495</url>
  </required_header>
  <id_info>
    <org_study_id>2008-023</org_study_id>
    <nct_id>NCT00768495</nct_id>
  </id_info>
  <brief_title>Hyperspectral Imaging Pre and Post Endovascular Intervention</brief_title>
  <acronym>CLI-Pre/Post</acronym>
  <official_title>Evaluation of the Success of Endovascular Peripheral Revascularization for the Treatment of Chronic Limb Ischemia by Measuring OxyHb and DeoxyHb Using a New Hyperspectral Imaging Device (OxyVu).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HyperMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cardiac, Vascular &amp; Thoracic Surgery Associates, P.C. (CVTSA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HyperMed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will collect tissue oxygenation data via hyperspectral imaging before and after
      endovascular procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a nonrandomized, nonblinded, prospective observational study to correlate the
      results obtained with the traditional measures of success of endovascular revascularization
      of peripheral arteries for the treatment of chronic limb ischemia; i.e., ABPI, PVR with
      oxyhemoglobin (OxyHb) and deoxyhemoglobin (DeoxyHb) measurements obtained with a new imaging
      device manufactured by HyperMed Inc (OxyVu) that uses hyperspectral technology.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Chronic Limb Ischemia</condition>
  <condition>Non-Healing Ulcers</condition>
  <arm_group>
    <arm_group_label>One Cohort</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have chronic limb ischemia and present with the symptoms of claudication, rest
        pain or having minor non-healing ulcers or gangrene (Rutherford category 1 to 6) who also
        require percutaneous endovascular revascularization.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with established diagnosis of lower limb ischemic based on their symptoms of
             claudication, rest pain, non-healing ulcers or gangrene and other vascular laboratory
             tests that are currently used to make this diagnosis and have been scheduled for
             endovascular revascularization.

          2. Age group between 50-85

          3. Gender - Male or Female

          4. Race - all race and ethnicities

        Exclusion Criteria:

          1. Patients with known cardiac disease - new MI (within 3 months).

          2. Patients with hypertension with the systolic BP &gt;200 or diastolic BP&gt;110 on the day of
             testing

          3. Patients on supplemental O2 for chronic obstructive lung disease

          4. Bed-ridden subjects - either due to chronic disability or neurological problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Schomacker, PhD</last_name>
    <role>Study Director</role>
    <affiliation>HyperMed</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kevin Scomacker, PhD</last_name>
    <phone>781-229-5900</phone>
    <email>kschomacker@hypermed-inc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cardiac, Vascular &amp; Thoracic Surgery Associates</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dipankar Mukherjee, MD</last_name>
      <phone>703-280-5858</phone>
      <phone_ext>1111</phone_ext>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hypermed-inc.com</url>
    <description>Sponsor and OxyVu technology website</description>
  </link>
  <reference>
    <citation>Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc. 2007 Apr;55(4):583-9.</citation>
    <PMID>17397438</PMID>
  </reference>
  <reference>
    <citation>White C. Clinical practice. Intermittent claudication. N Engl J Med. 2007 Mar 22;356(12):1241-50. Review.</citation>
    <PMID>17377162</PMID>
  </reference>
  <reference>
    <citation>Yao ST. Haemodynamic studies in peripheral arterial disease. Br J Surg. 1970 Oct;57(10):761-6.</citation>
    <PMID>5476754</PMID>
  </reference>
  <reference>
    <citation>Begelman SM, Jaff MR. Noninvasive diagnostic strategies for peripheral arterial disease. Cleve Clin J Med. 2006 Oct;73 Suppl 4:S22-9. Review.</citation>
    <PMID>17385388</PMID>
  </reference>
  <reference>
    <citation>Raines JK, Darling RC, Buth J, Brewster DC, Austen WG. Vascular laboratory criteria for the management of peripheral vascular disease of the lower extremities. Surgery. 1976 Jan;79(1):21-9.</citation>
    <PMID>1246689</PMID>
  </reference>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2008</study_first_submitted>
  <study_first_submitted_qc>October 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2008</study_first_posted>
  <last_update_submitted>June 2, 2009</last_update_submitted>
  <last_update_submitted_qc>June 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kevin Schomacker</name_title>
    <organization>HyperMed, Inc.</organization>
  </responsible_party>
  <keyword>revascularization</keyword>
  <keyword>claudication</keyword>
  <keyword>hyperspectral</keyword>
  <keyword>oxygenation</keyword>
  <keyword>limb ischemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

